Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical glycyrrhetinic acid / CMC-Na ointment for oral lichen planus
jRCTs031220306Completed
- Sponsor
- University of Tsukuba Hospital
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of glycyrrhetinic acid in oral lichen planus (OLP), sponsored by University of Tsukuba Hospital. Primary endpoints: Safety (clinical adverse events) and Safety (laboratory abnormalities). Started Aug 2023; status: completed.
02
Drugs
glycyrrhetinic acid
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on jRCTs031220306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220306.